Statistika RUNG

A+ | A- | SLO | ENG

Bibliografija osebe. Seznam zajema vsa gradiva in ne le tista, kje je oseba mentor.

Doktorska dela (3)

1. Sandra Oloketuyi: FUNCTIONALIZED NANOBODIES AS DIAGNOSTIC REAGENTS FOR THE DETECTION OF TOXIC MICROALGAE
2. Gbenga Folorunsho Oginni: Quantitative detection of Microcystis aeruginosa (cyanobacteria) in water using single domain antibodies (VHH)
3. Claudia D'Ercole: Development of molecular methods for the comprehensive evaluation of stress conditions affecting forest trees

Druga dela (144)

1. Elena Ambrosetti, Giulio Bernardinelli, Ian Hoffecker, Leonard Hartmanis, Georges Kiriako, Ario De Marco, Rickard Sandberg, Bjorn Hogberg, Ana Teixeira: A DNA-nanoassembly-based approach to map membrane protein nanoenvironments
2. Miguel Soler, Ario De Marco, Sara Fortuna: Computational design of customised nanobodies for biotechnological applications
3. Ario De Marco: Lo sviluppo biotecnologico della pallottola magica proposta nel 1906 da Paul Ehrlich, padre della chemioterapia
4. Ario De Marco: Lo sviluppo biotecnologico della pallottola magica proposta nel 1906 da Paul Ehrlich, padre della chemioterapia
5. Ario De Marco: Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs
6. Ario De Marco, Chiara Romani: Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery
7. Ario De Marco: Co-expression and co-purification of antigen-antibody complexes in bacterial cytoplasm and periplasm
8. Ario De Marco, Chiara Martinelli, Emanuela Colombo, Daniele Piccini, Cristina Sironi, Pier Giuseppe Pelicci: An intrabody specific for the nucleophosmin carboxy-terminal mutant and fused to a nuclear localization sequence binds its antigen but fails to relocate it in the nucleus
9. Ario De Marco: Recent contributions in the field of the recombinant expression of disulfide bonded proteins in bacteria
10. Ario De Marco, Mario Lebendiker, Tsafi Danieli: The Trip Adviser guide to the protein science world
11. Ario De Marco, Selma Djender, Anne Beugnet, Aurelie Schneider, Ronan Crepin, Klervi Even Desrumeaux, Chiara Romani, Sandrine Moutel, Franck Perez: Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
12. Ario De Marco: Selection criteria and engineering of nanobodies for oncological applications
13. Sandrine Moutel, Nicolas Bery, Virginie Bernard, Laura Keller, Emilie Lemesre, Ario De Marco, Laetitia Ligat, Jean-Christophe Rain, Gilles Fevre, Aurelien Olichon, Franck Perez: NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
14. Loredana Casalis, Elena Ambrosetti, Pietro Parisse, Alessandro Bosco, Ario De Marco, Elsa Tagliabue: A Nano-Imunoassay based on fluorescence and atomic force spectroscopy for the detection of circulating cancer biomarkers: The case of HER2 positive breast cancer
15. Miguel Soler, Ario De Marco, Sara Fortuna: Molecular dynamics simulations and docking enable to explore the biophysical factors controlling the yields of engineered nanobodies
16. Ario De Marco: Nanobodies for research & clinical applications
17. Ario De Marco: Nanobody technology: principles & applications
18. Ario De Marco: Assessment of the actual antibody-antigen binding conditions at the surface of biological membranes
19. Lidija Filipovic, Milica Spasojevic, Radivoje Prodanovic, Aleksandra Korac, Suzana Matijasevic, Goran Brajuskovic, Ario De Marco, Milica Popovic: Affinity-based isolation of extracellular vesicles by means of single-domain antibodies bound to macroporous methacrylate-based copolymer
20. Ario De Marco: Cytoplasmic production of nanobodies and nanobody-based reagents by co-expression of sulfhydryl oxidase and DsbC isomerase
21. Ario De Marco: Is there an approach for optimizing the specific binding of antibodies to target cells?
22. Ronan Crepin, David Gentien, Angeline Duche, Audrey Rapinat, Cecile Reyes, Fariba Nemati, Gerald Massonnet, Didier Deacaudin, Selma Djander, Sandrine Moutel, Klervi Even Desrumeaux, Nathalie Cassoux, Sophie Piperno-Neumann, Sebastian Amigorena, Franck Perez, Sergio Roman-Roman, Ario De Marco: Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma Patient Derived Xenografts
23. Ario De Marco: Nanobody technology: principles & applications
24. Ario De Marco: Biotechnological applications of nanobody pre-immune libraries
25. Ario De Marco: Nanobodies as biotechnological tools
26. Ario De Marco: Advantages offered by the nanobody format when highly-specific reagents are needed for biotechnological applications
27. Ario De Marco: Acting of folding effectors to improve recombinant protein yields and functional quality
28. Elena Ambrosetti, Pamela Paoletti, Alessandro Bosco, Pietro Parisse, Denis Scaini, Elda Tagliabue, Ario De Marco, Loredana Casalis: Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays
29. Ario De Marco, Milica Popovic: Canonical and selective approaches in exosome purification and their implications for diagnostic accuracy
30. Ario De Marco: Nuovi modelli di ricerca: oncologia comparativa per lo studio dei sarcomi
31. Ronan Crepin, Gianluca Veggiani, Selma Djender, Anne Beugnet, Francois Planeix, Christophe Pichon, Sandrine Moutel, Sebastian Amigorena, Franck Pérez, Nicolae Ghinea, Ario De Marco: Whole-cell biopanning with a synthetic phage display library of nanobodies enabled the recovery of follicle-stimulating hormone receptor inhibitors
32. Elisa Mazzega, Ario De Marco: Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs
33. Milica Popovič, Marco Gregori, Dominik Vodnik, Mitja Ferlan, Tanja Mrak, Ines Straus, Natahan McDowell, Hojka Kraigher, Ario De Marco: Identification of stress biomarkers for drought and increased soil temperature in seedlings of European beech (Fagus sylvatica L.)
34. Ario De Marco: Nanobodies: towards rational design of immune-reagents
35. Elisa Mazzega, Alfred Beran, Marina Cabrini, Ario De Marco: In vitro isolation of anti Alexandrium minutum nanobodies from a pre-immune library
36. Ario De Marco: Naked protein nanoparticles
37. Milica Popovic, Elisa Mazzega, Barbara Toffoletto, Ario De Marco: Isolation of anti‑extra‑cellular vesicle single‑domain antibodies by direct panning on vesicle‑enriched fractions
38. Miguel Soler, Sara Fortuna, Ario De Marco, Alessandro Laio: Binding affinity prediction of nanobody–protein complexes by scoring of molecular dynamics trajectories
39. Ario De Marco: A caccia di proteine usando gli anticorpi come esca
40. Ario De Marco: Nanomaterial bio-activation and macromolecules functionalization: the search for reliable protocols
41. Ario De Marco: Nanobodies: flexible structures for biotechnological applications
42. Bert Dhondt, Jan Van Deun, Silke Vermaerke, Ario De Marco, Nicolaas Lumen, Olivier De Wever, An Hendrix: Urinary Extracellular Vesicle Biomarkers in Urological Cancers: From Discovery Towards Clinical Implementation
43. Tanja Peric, Martina Bergant Marušič, Ario De Marco, Petra Makorič, Sinan Ogun: How to react to the necessity of a sustainable animal production? The EcoLamb project
44. Ario De Marco: Pre-immune nanobody collections and their biotechnological applications
45. Ario De Marco: Nanobodies: a flexible technological platform
46. Ario De Marco: Nanobodies as convenient reagents for multiple biotechnological applications
47. Ario De Marco: In vitro and in silico approaches to obtain tailored reagents – Nanobodies as model
48. Ario De Marco: A comprehensive nanobody platform to answer to diversified biotechnological needs
49. Ario De Marco: Nanobodies as convenient reagents for multiple biotechnological applications
50. Ario De Marco: Nanobody represent a platform to answer to diversified biotechnological needs
51. Tanja Batkovič, Mojca Zotler, Meta Križaj, Jan David, Dani Bratuž, Anže Kuraj: Toxins in microalgae
52. Pieranna Chiarella, Renata Sisto, Ario De Marco: Confronting two biomolecular techniques to detect NRF2 gene polymorphism biomarkers
53. Elisa Mazzega, Ario De Marco, Marina Cabrini, Alfred Beran: Recombinant nanobodies as cheap and customizable reagents for unicellular algae detection
54. Ario De Marco, Neus Ferrer-Miralles, Elena Garcia-Fruitos, Anna Mitraki, Spela Peternel, Ursula Rinas, Mauricio Trujillo-Roldan, Norma Valdez-Cruz, Esther Vazquez, Antonio Villaverde: Bacterial inclusion bodies are industrially exploitable amyloids.
55. Elisa Mazzega, Alfred Beran, Marina Cabrini, Ario De Marco: In vitro isolation of nanobodies for selective Alexandrium minutum recognition: a model for convenient development of dedicated immuno-reagents to study and diagnostic toxic unicellular algae
56. Ario De Marco: Multi-disciplinary approaches for designing new generation antibodies
57. Sandra Oloketuyi, Carina Dilkaute, Elisa Mazzega, Joachim Jose, Ario De Marco: Purification-independent immunoreagents obtained by displaying nanobodies on bacteria surface
58. Ario De Marco: Nanobodies: How to Exploit Pre-Immune Libraries and Recombinant Antibody Fragments
59. Ario De Marco: Reshaping metropolitan transportation cultures. A comparative study of bicycle friendly cities in Europe and the case of the Metropolitan City of Milano
60. BMC Biotechnology
61. Robert Alvin Bernedo-Navarro, Sandra Oloketuyi, Giulio Bernardinelli, Eda Mehmeti, Kurt Kalcher, Ario De Marco: Nanobody Engineering Provides Diagnostic Reagents For The Quantification Of The Toxic Microalgae Alexandrium minutum
62. Ario De Marco: Combining in vitro panning of nanobody pre-immune libraries with sequence (rational) engineering to get application-tailored reagents
63. Ario De Marco: Nanobodies as a platform of flexible tools suitable for diversified biotechnological needs
64. Ario De Marco, Gianluca Veggiani, Barbara Giabbai, Marta Semrau, Barbara Medagli, Vincenzo Riccio, Gregor Bajc, Paola Storici: Comparative analysis of fusion tags used to functionalize recombinant antibodies
65. Ario De Marco: Metrics and evaluation of scientific productivity: would it be useful to normalize the data taking in consideration the investments?
66. Giulio Bernardinelli, Sandra Oloketuyi, Franziska Werner, Elisa Mazzega, Bjorn Hogberg, Ario De Marco: A compact nanobody-DNAzyme conjugate enables antigen detection and signal amplification
67. Ario De Marco: Nanobodies as a flexible biotechnological platform
68. Gbenga Folorunsho Oginni, Sandra Oloketuyi, Elisa Mazzega, Mladen Franko, Hanna Budasheva, Dorota Korte, Ario De Marco: Quantitative detection of Microcystis aeruginosa in fresh water using single domain antibodies (VHHs)
69. Sandra Oloketuyi, Carina Dilkaute, Elisa Mazzega, Joachim Jose, Ario De Marco: Bacterial surface display of nanobodies against cancer and toxic micoalgal cells
70. Sandra Oloketuyi, Elisa Mazzega, Eda Mehmeti, Kurt Kalcher, Ario De Marco: Functionalized nanobodies: A bio-recognition molecule for the detection of the toxic microalgae Alexandrium minutum by means of an electrochemical immunosensor
71. Miguel Soler, Barbara Medagli, Marta S. Semrau, Paola Storici, Gregor Bajc, Ario De Marco, Alessandro Laio, Sara Fortuna: A consensus protocol for the in silico optimisation of antibody fragments
72. Tanja Peric, Martina Bergant Marušič, Ario De Marco, Petra Makorič: How to react to the necessity of a sustainable animal production? The EcoLamb project.
73. Stephan Uebel, Ario De Marco, Nick Berrow, Mario Lebendiker, Maria Garcia-Alai, Stefan Knauer, Blanca Lopez-Mendez, Andrea Matagne, Annabel Parret, Kim Remans, Bertrand Raynal: Quality Control of Purified Proteins to Improve Research Data Reproducibility
74. Sandra Oloketuyi, Elisa Mazzega, Janez Zavašnik, Kingkan Pungjunun, Kurt Kalcher, Ario De Marco, Eda Mehmeti: Electrochemical immunosensor functionalized with nanobodies for the detection of the toxic microalgae Alexandrium minutum using glassy carbon electrode modified with gold nanoparticles
75. Ario De Marco: Pre-immune libraries of recombinant nanobodies: outcome from 15-year experience
76. Ario De Marco: Nanobodies isolated from pre-immune libraries as tunable biotechnological tools
77. Ario De Marco: Opportunities offered by recombinant antibody technology: our 15-year experience with nanobodies
78. Ario De Marco: Recombinant expression of nanobodies and nanobody-derived immunoreagents
79. Sandra Oloketuyi, Giulia Annovi, Ario De Marco: Peroxidase zymograms obtained by agarose native gel electrophoresis have unmet resolution and completeness
80. Matic Kovačič, Gregor Ilc, Ario De Marco: A10 nanobody protein backbone assignation
81. Ivana Pandža, Katja Belec, Matjaž Žvokelj, Merima Vrškić, Tajda Huber, Ula Urbas: OBJECTIVE AND PERCEIVED ENVIRONMENTAL QUALITY IN THE TOWNS OF ZENICA AND MARIBOR
82. Ario De Marco: Recombinant proteins co-expressed and co-purified in the presence of antibody fragments
83. Miguel Soler, Barbara Medagli, Jiewen Wang, Sandra Oloketuyi, Gregor Bajc, He Huang, Sara Fortuna, Ario De Marco: Effect of Humanizing Mutations on the Stability of the Llama Single-Domain Variable Region
84. Nick Berrow, Ario De Marco, Mario Lebendiker, Maria Garcia-Alai, Stefan H. Knauer, Blanca Lopez-Mendez, Andre Matagne, Annabel Parret, Kim Remans, Stephan Uebel, Bertrand Raynal: Quality control of purified proteins to improve data quality and reproducibility: results from a large-scale survey
85. Daniele Ubbiali, Marco Orlando, Matic Kovačič, Claudio Iacobucci, Marta S. Semrau, Gregor Bajc, Sara Fortuna, Gregor Ilc, Barbara Medagli, Sandra Oloketuyi, Ario De Marco: An anti-HER2 nanobody binds to its antigen HER2 via two independent paratopes
86. Gbenga Folorunsho Oginni, Sandra Oloketuyi, Elisa Mazzega, Hanna Budasheva, Alfred Beran, Marina Cabrini, Dorota Korte, Mladen Franko, Ario De Marco: Nanobody-dependent detection of microcystis aeruginosa by ELISA and thermal lens spectrometry
87. Yoav Peleg, Renaud Vincentelli, Brett M. Collins, Kai-En Chen, Emma K. Livingstone, Saroja Weeratunga, Natalya Leneva, Qian Guo, Kim Remans, Ario De Marco: Community-wide experimental evaluation of the PROSS stability-design method
88. Ario De Marco, Nick Berrow, Mario Lebendiker, Maria Garcia-Alai, Stefan H. Knauer, Blanca Lopez-Mendez, Andre Matagne, Annabel Parret, Kim Remans, Stephan Uebel, Bertrand Raynal: Quality control of protein reagents for the improvement of research data reproducibility
89. Laura Sánchez-García, Eric Voltà-Durán, Eloi Parladé, Elisa Mazzega, Alejandro Sánchez-Chardi, Naroa Serna, Hèctor López-Laguna, Mara Mitstorfer, Ugutz Unzueta, Esther Vázquez, Antonio Villaverde, Ario De Marco: Self-assembled nanobodies as selectively targeted, nanostructured, and multivalent materials
90. Marco Orlando, Sara Fortuna, Sandra Oloketuyi, Gregor Bajc, Adi Goldenzweig, Ario De Marco: CDR1 composition can affect nanobody recombinant expression yields
91. Hèctor López-Laguna, Julieta M. Sánchez, José Vicente Carratalá, Mauricio Rojas-Peña, Laura Sánchez-García, Eloi Parladé, Alejandro Sánchez-Chardi, Eric Voltà-Durán, Naroa Serna, Ario De Marco: Biofabrication of functional protein nanoparticles through simple His-tag engineering
92. Patrik Cingerli, Katarina Erker, Nina Žvab-Pernat, Darian Rampih, Miroslav Štrbac, Hena Zukić, Kenan Kapetanović: Identification of environmental stress conditions by comparative analysis of peroxidase activity in betulla pendula and pinus sp.
93. Serena D'Agostino, Elisa Mazzega, Katja Praček, Sara Piccinin, Flavia Pivetta, Michela Armellin, Sara Fortuna, Roberta Maestro, Ario De Marco: Interference of p53:Twist1 interaction through competing nanobodies
94. Sandra Oloketuyi, Robert Alvin Bernedo-Navarro, Andreas Christmann, Justyna Borkowska, Giulia Cazzaniga, Horst Wilhelm Schuchmann, Joanna Niedziółka-Jönsson, Katarzyna Szot-Karpińska, Harald Kolmar, Ario De Marco: Native llama nanobody library panning performed by phage and yeast display provides binders suitable for C-reactive protein detection
95. Jiewen Wang, Guangbo Kang, Haibin Yuan, Xiaocang Cao, He Huang, Ario De Marco: Research progress and applications of multivalent, multispecific and modified nanobodies for disease treatment
96. Eric Voltà-Durán, Julieta M. Sánchez, Hèctor López-Laguna, Eloi Parladé, Laura Sánchez-García, Alejandro Sánchez-Chardi, Ario De Marco, Ugutz Unzueta, Esther Vázquez, Antonio Villaverde: The spectrum of building block conformers sustains the biophysical properties of clinically-oriented self-assembling protein nanoparticles
97. Matteo De March, Michela Terdoslavich, Sulena Polez, Corrado Guarnaccia, Monica Poggianella, Alessandro Marcello, Nataša Skoko, Ario De Marco: Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
98. Kim Remans, Mario Lebendiker, Celeste Abreu, Mariano Maffei, Shaila Sellathurai, Marina May, Ondrej Vanek, Ario De Marco: Protein purification strategies must consider downstream applications and individual biological characteristics
99. Ario De Marco, Lucio Barile: Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
100. Ario De Marco: Ligands based on monomeric scaffolds - formats and applications
101. Ario De Marco: Opportunities offered by recombinant ligands
102. Ario De Marco: Recombinant ligands as tunable biotechnological tools
103. Sarah Barakat, Mustafa Tunçay, Alp Ertunga Eyupoglu, Emre Vatandaşlar, Ario De Marco, Batu Erman: Identification of nanobodies targeting the BTB domain of the PATZ1 transcription factor
104. Martina Bergant Marušič, Ario De Marco: Diagnostics and Monitoring of COVID-19 Infection – Current Understanding
105. Ario De Marco: Recombinant proteins as intermediate reagents
106. Zixuan Bai, Jiewen Wang, Jiaqi Liu, Haibin Yuan, Ping Wang, Miao Zhang, Yuanhang Feng, Xiangtong Cao, Xiangan Cao, Guangbo Kang, Ario De Marco, He Huang: Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations
107. Daniel J. Nieves, Jeremy A. Pike, Florian Levet, David J. Williamson, Mohammed Baragilly, Sandra Oloketuyi, Ario De Marco, Juliette Griffié, Daniel Sage, Edward A. K. Cohen: A framework for evaluating the performance of SMLM cluster analysis algorithms
108. Ario De Marco: Development of strategies and molecular tools for obtaining application-friendly recombinant ligands
109. Monica Poggianella, Robert Alvin Bernedo-Navarro, Sandra Oloketuyi, Ario De Marco: Nanobodies selectively binding to the idiotype of a dengue virus neutralizing antibody do not necessarily mimic the viral epitope
110. Julia Neumair, Claudia D'Ercole, Matteo De March, Martin Elsner, Michael Seidel, Ario De Marco: Macroporous epoxy-based monoliths functionalized with anti-CD63 nanobodies for effective isolation of extracellular vesicles in urine
111. Kim Remans, Ario De Marco, Nick Berrow, Mario Lebendiker, Maria Garcia-Alai, Stefan Knauer, Andre Matagne, Anne Perret, Stephan Uebel, Bertrand Raynal: Protein quality control for improved data reproducibility and reliability
112. Ario De Marco: Combining panning design and expression options allows obtaining nanobodies trimmed for specific applications
113. Ario De Marco: Smaller and smaller
114. Ario De Marco: Recent advances in recombinant production of soluble proteins in E. coli
115. Jiaqi Liu, Guangbo Kang, Jiewen Wang, Haibin Yuan, Yili Wu, Shuxian Meng, Ping Wang, Miao Zhang, Yuli Wang, Yuanhang Feng, He Huang, Ario De Marco: Affinity maturation of antibody fragments
116. Claudia D'Ercole, Ario De Marco: Isolation of adhirons specific for plant protoplast membrane biomarkers is simplified by phagemid design
117. Suchanat Boonkaew, Katarzyna Szot-Karpińska, Joanna Niedziółka-Jönsson, Ario De Marco, Martin Jönsson-Niedziółka: NFC smartphone-based electrochemical microfluidic device integrated with nanobody recognition for C-reactive protein
118. Ario De Marco: Mechanisms underlying the efficacy and safety of IgG, antibody fragments, and design immune biologics
119. Ario De Marco: From nanobodies to reagents: developability, optimization, expression opportunities, multivalent and multispecific formats
120. Ario De Marco: Ligand libraries: scaffold choice, generation and validation, screening strategies, clone evaluation
121. Claudia D'Ercole, Ario De Marco: Native agarose gels and contact blotting as means to optimize the protocols for the formation of antigen-ligand complexes
122. Claudia D'Ercole, Matteo De March, Gianluca Veggiani, Sandra Oloketuyi, Rossella Svigelj, Ario De Marco: Biological applications of synthetic binders isolated from a conceptually new adhiron library
123. Ario De Marco: Protein quality assessment: why & how
124. Anja Schütz, Frank Bernhard, Nick Berrow, Johannes F. Buyel, Frederico Ferreira-da-Silva, Jurgen Haustraete, Joop Van den Heuvel, Jan-Erik Hoffmann, Ario De Marco, Yoav Peleg: A concise guide to choosing suitable gene expression systems for recombinant protein production
125. Jiewen Wang, Guangbo Kang, Huiying Lu, Ario De Marco, Haibin Yuan, Zelin Feng, Mengxue Gao, Xiaoli Wang, Huahong Wang, Xiaolan Zhang: Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-▫$\alpha$▫ and IL-23p19 bioactivities
126. Ario De Marco: Implications of nanobody library design
127. Ario De Marco: Imagination is the limit for nanobody applications
128. Ario De Marco: The long march of nanobodies
129. Suchanat Boonkaew, Katarzyna Szot-Karpińska, Joanna Niedziółka-Jönsson, Ario De Marco, Martin Jönsson-Niedziółka: NFC smartphone-based electrochemical microfluidic device integrated with nanobody recognition for C-reactive protein
130. Claudia D'Ercole, Ario De Marco: Native agarose gels and contact blotting as means to optimize the protocols for the formation of antigen-ligand complexes
131. Yossma Waheed, Aditya Mojumdar, Mohammad Shafiq, Ario De Marco, Matteo De March: The fork remodeler helicase-like transcription factor in cancer development
132. Claudia D'Ercole: Instruct-ERIC network
133. Urša Štrancar, Claudia D'Ercole, Lucia Cikatricisová, Mirna Nakić, Matteo De March, Ario De Marco: A practical guide for the quality evaluation of fluobodies/chromobodies
134. Rossella Svigelj, Ario De Marco: Biological and technical factors affecting the point-of-care diagnostics in not-oncological chronic diseases
135. Lidija Filipović, Milica Spasojević Savković, Radivoje Prodanović, Suzana Matijašević Joković, Sanja Stevanović, Ario De Marco, Maja Kosanović, Goran Brajušković, Milica Popovic: Urinary extracellular vesicles as a readily available biomarker source
136. Ario De Marco: Recombinant antibodies
137. Ario De Marco: Identification of micro-organisms by means of Point-of-Care (PoC) biosensors
138. Ario De Marco: Harnessing in vitro selection opportunities for obtaining epitope-specific binders
139. Martin Ljubič, Claudia D'Ercole, Yossma Waheed, Ario De Marco, Jure Borišek, Matteo De March: Computational study of the HLTF ATPase remodeling domain suggests its activity on dsDNA and implications in damage tolerance
140. Scienza senza confini
141. Huyen Thuc Tran Luong, Dominique Revets, Matteo De March, Sofie Vercammen, Hilde De Rooster, Ario De Marco, Antonio Cosma: Common targetable biomarkers in canine hemangiosarcoma and human angiosarcoma
142. Barbora Kalouskova, Ondřej Skořepa, Jan Bláha, Lucia Cikatricisová, Ario De Marco, Ondřej Vaněk, Mario Brameshuber: Understanding the nanoscale organization of natural killer cell receptor NKp30 at the singlemolecule level
143. Claudia D'Ercole, Rossella Svigelj, Tanja Mrak, Ario De Marco: Early stress detection in forest trees using a nanobody-functionalized electrochemical biosensor for ascorbate peroxidase
144. Orkid Coskuner-Weber, Semih Alpsoy, Ozgur Yolcu, Egehan Teber, Ario De Marco, Spase Shumka: Metagenomics studies in aquaculture systems